Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue. 2005

Ingrid Karlsson, and Jean-Charles Grivel, and Silvia Sihui Chen, and Anders Karlsson, and Jan Albert, and Eva Maria Fenyö, and Leonid B Margolis
Unit of Virology, Division of Medical Microbiology, Department of Laboratory Medicine, Lund University, Sweden. Ingrid.Karlsson@mmb.lu.se

In the course of human immunodeficiency virus (HIV) disease, CCR5-utilizing HIV type 1 (HIV-1) variants (R5), which typically transmit infection and dominate its early stages, persist in approximately half of the infected individuals (nonswitch virus patients), while in the other half (switch virus patients), viruses using CXCR4 (X4 or R5X4) emerge, leading to rapid disease progression. Here, we used a system of ex vivo tonsillar tissue to compare the pathogeneses of sequential primary R5 HIV-1 isolates from patients in these two categories. The absolute replicative capacities of HIV-1 isolates seemed to be controlled by tissue factors. In contrast, the replication level hierarchy among sequential isolates and the levels of CCR5(+) CD4(+) T-cell depletion caused by the R5 isolates seemed to be controlled by viral factors. R5 viruses isolated from nonswitch virus patients depleted more target cells than R5 viruses isolated from switch virus patients. The high depletion of CCR5(+) cells by HIV-1 isolates from nonswitch virus patients may explain the steady decline of CD4(+) T cells in patients with continuous dominance of R5 HIV-1. The level of R5 pathogenicity, as measured in ex vivo lymphoid tissue, may have a predictive value reflecting whether, in an infected individual, X4 HIV-1 will eventually dominate.

UI MeSH Term Description Entries
D008212 Lymphocyte Depletion Immunosuppression by reduction of circulating lymphocytes or by T-cell depletion of bone marrow. The former may be accomplished in vivo by thoracic duct drainage or administration of antilymphocyte serum. The latter is performed ex vivo on bone marrow before its transplantation. Depletion, Lymphocyte
D008297 Male Males
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D019713 Receptors, CCR5 CCR receptors with specificity for CHEMOKINE CCL3; CHEMOKINE CCL4; and CHEMOKINE CCL5. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; MACROPHAGES; MAST CELLS; and NK CELLS. The CCR5 receptor is used by the HUMAN IMMUNODEFICIENCY VIRUS to infect cells. Antigens, CD195,CC Chemokine Receptor 5,CCR5 Receptors,CD195 Antigens,CC-CKR5,CCR5 Receptor,CKR5 Receptors,Receptors, CKR5,Receptor, CCR5

Related Publications

Ingrid Karlsson, and Jean-Charles Grivel, and Silvia Sihui Chen, and Anders Karlsson, and Jan Albert, and Eva Maria Fenyö, and Leonid B Margolis
November 2007, Journal of virology,
Ingrid Karlsson, and Jean-Charles Grivel, and Silvia Sihui Chen, and Anders Karlsson, and Jan Albert, and Eva Maria Fenyö, and Leonid B Margolis
November 2004, Journal of virology,
Ingrid Karlsson, and Jean-Charles Grivel, and Silvia Sihui Chen, and Anders Karlsson, and Jan Albert, and Eva Maria Fenyö, and Leonid B Margolis
April 2005, Journal of virology,
Ingrid Karlsson, and Jean-Charles Grivel, and Silvia Sihui Chen, and Anders Karlsson, and Jan Albert, and Eva Maria Fenyö, and Leonid B Margolis
January 2003, Journal of virology,
Ingrid Karlsson, and Jean-Charles Grivel, and Silvia Sihui Chen, and Anders Karlsson, and Jan Albert, and Eva Maria Fenyö, and Leonid B Margolis
December 1998, Journal of virology,
Ingrid Karlsson, and Jean-Charles Grivel, and Silvia Sihui Chen, and Anders Karlsson, and Jan Albert, and Eva Maria Fenyö, and Leonid B Margolis
March 2002, Journal of virology,
Ingrid Karlsson, and Jean-Charles Grivel, and Silvia Sihui Chen, and Anders Karlsson, and Jan Albert, and Eva Maria Fenyö, and Leonid B Margolis
October 2009, Journal of virology,
Ingrid Karlsson, and Jean-Charles Grivel, and Silvia Sihui Chen, and Anders Karlsson, and Jan Albert, and Eva Maria Fenyö, and Leonid B Margolis
January 1992, Current topics in microbiology and immunology,
Ingrid Karlsson, and Jean-Charles Grivel, and Silvia Sihui Chen, and Anders Karlsson, and Jan Albert, and Eva Maria Fenyö, and Leonid B Margolis
November 1998, Journal of virology,
Ingrid Karlsson, and Jean-Charles Grivel, and Silvia Sihui Chen, and Anders Karlsson, and Jan Albert, and Eva Maria Fenyö, and Leonid B Margolis
July 2004, Journal of virology,
Copied contents to your clipboard!